New App can Help Doctors Predict Risk of Preterm Birth

A new app called QUiPP could help doctors to better identify women at risk of giving birth prematurely. The app, developed at King's College London, was tested in two studies of high-risk women being monitored at ante-natal clinics. Worldwide 15 million babies are born preterm (before 37 weeks) each year and over a million of these die of prematurity-related complications. A number of factors are used to determine if a woman is at risk of giving birth prematurely, including a history of preterm births or late miscarriages. Two further factors which doctors can consider are the length of cervix and levels of a biomarker found in vaginal fluid known as fetal fibronectin, which are typically tested from 23 weeks. The investigators have further developed the fetal fibronectin test to be accurately used from the first half of pregnancy.

The app developed at King's uses an algorithm which combines the gestation of previous pregnancies and the length of the cervix with levels of fetal fibronectin to classify a woman's risk. The first study focused on women deemed to be a high risk of preterm birth, usually because of a previous early pregnancy, despite not showing any symptoms. The second study predicted the likelihood of early delivery in a group of women showing symptoms of early labour which often doesn't progress to real labour.

In the first study, published in the journal Ultrasound in Obstetrics & Gynecology, researchers collected data from 1,249 women at high risk for pre-term birth attending pre-term surveillance clinics. The model was developed on the first 624 consecutive women and validated on the subsequent 625. The estimated probability of delivery before 30, 34 or 37 weeks' gestation and within two or four weeks of testing for fetal fibronectin was calculated for each patient and analyzed as a predictive test for the actual occurrence of each event.

In the second study, also published in the journal Ultrasound in Obstetrics & Gynecology, data from 382 high-risk women was collected. The model was developed on the first 190 women and validated on the remaining 192. Probabilities of delivering early were estimated as above.

In both studies, the app was found to perform well as a predictive tool, and far better than each component (previous pregnancy, cervical length or fetal fibronectin) taken alone.

The authors conclude that the app can be used by clinicians to improve the estimation of the probability of premature delivery (before 34 weeks' gestation or within two weeks of the fetal fibronectin test) and to potentially tailor clinical management decisions.

However, further work is needed to clinically evaluate the model in practice, and to ascertain whether interventions improve the pregnancy outcome for women identified as high risk by the app.

Professor Andrew Shennan, lead author who is Professor of Obstetrics at King's College London and consultant obstetrician at Guy's and St Thomas' NHS Foundation Trust, said:

"Despite advances in prenatal care the rate of preterm birth has never been higher in recent years, including in the US and UK, so doctors need reliable ways of predicting whether a woman is at risk of giving birth early. It can be difficult to accurately assess a woman's risk, given that many women who show symptoms of preterm labour do not go on to deliver early.

"The more accurately we can predict her risk, the better we can manage a woman's pregnancy to ensure the safest possible birth for her and her baby, only intervening when necessary to admit these 'higher risk' women to hospital, prescribe steroids or offer other treatments to try to prevent an early birth."

QUiPP is available to download for free from the Apple store.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...

AI Detects Hidden Heart Disease Using Ex…

Mass General Brigham researchers have developed a new AI tool in collaboration with the United States Department of Veterans Affairs (VA) to probe through previously collected CT scans and identify...

AI Medical Receptionist Modernizing Doct…

A virtual medical receptionist named "Cassie," developed through research at Texas A&M University, is transforming the way patients interact with health care providers. Cassie is a digital-human assistant created by Humanate...

Using Data and AI to Create Better Healt…

Academic medical centers could transform patient care by adopting principles from learning health systems principles, according to researchers from Weill Cornell Medicine and the University of California, San Diego. In...

AI Tool Set to Transform Characterisatio…

A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI tool to better characterise the diversity of individual cells within...

Human-AI Collectives Make the Most Accur…

Diagnostic errors are among the most serious problems in everyday medical practice. AI systems - especially large language models (LLMs) like ChatGPT-4, Gemini, or Claude 3 - offer new ways...

MHP-Net: A Revolutionary AI Model for Ac…

Liver cancer is the sixth most common cancer globally and a leading cause of cancer-related deaths. Accurate segmentation of liver tumors is a crucial step for the management of the...

Northern Ireland Completes Nationwide Ro…

Go-lives at Western and Southern health and social care trusts mean every pathology service is using the same laboratory information management system; improving efficiency and quality. An ambitious technology project to...